Ian A. Lorimer
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Transglutaminase 2 function in glioblastoma tumor efferocytosis.
Journal: Cell death & disease
Published: September 30, 2024
Potential roles for efferocytosis in glioblastoma immune evasion.
Journal: Neuro-oncology advances
Published: April 15, 2024
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 06, 2023
Avelumab in newly diagnosed glioblastoma.
Journal: Neuro-oncology advances
Published: October 04, 2021
Engineered cells as glioblastoma therapeutics.
Journal: Cancer gene therapy
Published: January 18, 2021
Identification of Rac guanine nucleotide exchange factors promoting Lgl1 phosphorylation in glioblastoma.
Journal: The Journal of biological chemistry
Published: December 07, 2020
Engineering PTEN-L for Cell-Mediated Delivery.
Journal: Molecular therapy. Methods & clinical development
Published: June 24, 2017
Induction of senescence in primary glioblastoma cells by serum and TGFβ.
Journal: Scientific reports
Published: September 27, 2016
Control of glioblastoma tumorigenesis by feed-forward cytokine signaling.
Journal: Nature neuroscience
Published: January 29, 2016
Last Updated: 09/26/2026